Needham & Company LLC reiterated their buy rating on shares of Enovis (NYSE:ENOV - Free Report) in a report issued on Wednesday morning,Benzinga reports. The brokerage currently has a $64.00 price target on the stock.
Enovis Trading Down 0.5 %
NYSE:ENOV traded down $0.17 on Wednesday, reaching $31.93. 1,011,678 shares of the stock traded hands, compared to its average volume of 733,297. The firm has a market capitalization of $1.82 billion, a price-to-earnings ratio of -14.58 and a beta of 1.86. Enovis has a 1-year low of $29.32 and a 1-year high of $59.63. The company has a current ratio of 2.27, a quick ratio of 1.12 and a debt-to-equity ratio of 0.40. The company's 50 day moving average is $38.85 and its 200-day moving average is $42.55.
Enovis (NYSE:ENOV - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.92 by $0.06. The company had revenue of $560.98 million during the quarter, compared to analysts' expectations of $555.14 million. Enovis had a negative net margin of 5.95% and a positive return on equity of 4.39%. Equities research analysts anticipate that Enovis will post 2.79 EPS for the current fiscal year.
Hedge Funds Weigh In On Enovis
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Confluence Investment Management LLC purchased a new position in shares of Enovis in the fourth quarter valued at $3,494,000. Geode Capital Management LLC increased its holdings in Enovis by 9.5% during the 3rd quarter. Geode Capital Management LLC now owns 921,437 shares of the company's stock valued at $39,678,000 after purchasing an additional 80,165 shares during the period. UMB Bank n.a. raised its holdings in Enovis by 128.2% in the 4th quarter. UMB Bank n.a. now owns 778 shares of the company's stock worth $34,000 after purchasing an additional 437 shares in the last quarter. Jane Street Group LLC lifted its stake in shares of Enovis by 247.6% in the 3rd quarter. Jane Street Group LLC now owns 106,684 shares of the company's stock valued at $4,593,000 after purchasing an additional 75,988 shares during the period. Finally, Envestnet Portfolio Solutions Inc. lifted its holdings in shares of Enovis by 19.5% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,433 shares of the company's stock valued at $677,000 after purchasing an additional 2,518 shares during the last quarter. 98.45% of the stock is owned by hedge funds and other institutional investors.
Enovis Company Profile
(
Get Free Report)
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.
Featured Stories
Before you consider Enovis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovis wasn't on the list.
While Enovis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
